Oral administration of myelin induces antigen-specific TGF-β1-secreting T cells in multiple sclerosis patients

Annals of the New York Academy of Sciences

Volumn 815, Issue , 1997, Pages 412-422

  Kent, Sally C ^a   Fukaura, Hikoaki ^a   Pietrusewicz, Matthew J ^a   Khoury, Samia J ^a   Weiner, Howard L ^a   Hafler, David A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MYELIN; MYELIN BASIC PROTEIN; MYLORAL; PROTEOLIPID PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ANTIGEN SPECIFICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; IMMUNOLOGICAL TOLERANCE; MULTIPLE SCLEROSIS; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; T LYMPHOCYTE;

EID: 0030762538     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb52092.x     Document Type: Conference Paper

References (32)

1. MCFARLIN, D. E. & H. F. MCFARLAND. 1982. Multiple sclerosis. N. Engl. J. Med. 307: 1183-1188.
2. HAFLER, D. A. & H. L. WEINER. 1995. Immunologic mechanisms and therapy in multiple sclerosis. Immunol. Rev. 144: 75-107.
3. ZAMVIL, S., P. NELSON, J. TROTTER, D. MITCHELL, R. KNOBLER, R. FRITZ & L. STEINMAN. 1985. T cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 317: 355-358.
4. TUOHY, V. K., R. A. SOBEL & M. B. LEES. 1988. Myelin proteolipid protein-induced experimental allergic encephalomyelitis: variations of disease expression in different strains of mice. J. Immunol. 140: 1868-1873.
5. LININGTON, C., T. BERGER, L. PERRY, S. WEERTH, D. HINZE-SELCH, Y. ZHANG, H. C. LU, H. LASSMANN & H. WEKERLE. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23: 1364-1372.
6. KHOURY, S. J., W. W. HANCOCK & H. L. WEINER. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, interleukin-4, and prostaglandin E expression in the brain. J. Exp. Med. 176: 1355-1364.
7. CHASE, M. W. 1946. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc. Soc. Exp. Biol. Med. 61: 257-259.
8. MOWAT, A. M. 1987. The regulation of immune response to dietary protein antigens. Immunol. Today 8: 93-98.
9. HIGGINS, P. J. & H. L. WEINER. 1988. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140: 440-445.
10. BITAR, D. M. & C. C. WHITACRE. 1988. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112: 364-370.
11. THOMPSON, H. S. & N. A. STAINES. 1986. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin. Exp. Immunol. 64: 581-586.
12. NAGLER-ANDERSON, C., L. A. BOBER, M. E. ROBINSON, G. W. SISKIND & G. J. THORBECKE. 1986. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. U.S.A. 83: 7443-7446.
13. ZHANG, Z. J., C. S. Y. LEE, O. LIDER & H. L. WEINER. 1990. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145: 2489-2493.
14. NUSSENBLATT, R. B., R. R. CASPI, R. MAHDI, C-C. CHAN, F. ROBERGE, O. LIDER & H. L. WEINER. 1990. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 144: 1689-1695.
15. ZHANG, Z. J., L. DAVIDSON, G. EISENBARTH & H. L. WEINER. 1991. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. U.S.A. 88: 10252-10256.
16. WEINER, H. L., G. A. MACKLIN, M. MATSUI, E. J. ORAV, S. J. KHOURY, D. M. DAWSON & D. A. HAFLER. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
17. TRENTHAM, D. E., R. A. DYNESIUS-TRENTHAM, E. J. ORAV, D. COMBITCHI, C. LORENZO, K. L. SEWELL, D. A. HAFLER & H. L. WEINER. 1993. Effects of oral administration of type II collagen on rheumatoid arthritis. Science 261: 1727-1730.
18. HOHOL, M. J., S. J. KHOURY, S. L. COOK, E. J. ORAV, D. A. HAFLER & H. L. WEINER. 1996. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Ann. N.Y. Acad. Sci. 778: 243-250.
19. MILLER, A., O. LIDER & H. L. WEINER. 1991. Antigen-driven bystander suppression following oral administration of antigens. J. Exp. Med. 174: 791-798.
20. CHEN, Y., V. K. KUCHROO, J-I. INOBE, D. A. HAFLER & H. L. WEINER. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237-1240.
21. CHEN, Y., J-I. INOBE, V. K. KUCHROO, J. L. BARON, C. A. JANEWAY, JR. & H. L. WEINER. 1996. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. U.S.A. 93: 388-391.
22. CHOU, F. C-H., C-H. J. CHOU, R. SHAPIRA & R. F. KIELER. 1976. Basis of microheterogeneity of myelin basic protein. J. Biol. Chem. 251: 2671-2679.
23. BIZZOZERO, O. A., G. ZUNIGA & M. B. LEES. 1991. Fatty acid composition of human myelin proteolipid protein in peroxisomal disorders. J. Neurochem. 56: 872-878.
24. FUKAURA, H., S. C. KENT, M. J. PIETRUSEWICZ, S. J. KHOURY, H. L. WEINER & D. A. HAFLER. 1996. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98: 70-77.
25. MILLER, A., O. LIDER, A. B. ROBERTS, M. B. SPORN & H. L. WEINER. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. U.S.A. 89:421-425.
26. LEBMAN, D. A., F. D. LEE & R. L. COFFMAN. 1990. Mechanism for transforming growth factor β and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J. Immunol. 144: 952-959.
27. KAGNOFF, M. F. & P. H. KLM. 1991. Effects of transforming growth factor beta-1 and interleukin-5 on IgA isotype switching at the clonal level. Immunol. Res. 10: 396-399.
28. CERWENKA, A., D. BEVEC, O. MAJDIC, W. KNAPP & W. HOLTER. 1994. TGF-beta 1 is a potent inducer of human effector T cells. J. Immunol. 153:4367-4377.
29. WAHL, S. M., N. MCCARTHY-FRANCIS & S. E. MERGENHAGEN. 1989. Inflammatory and immunomodulatory roles of TGFβ. Immunol. Today 10: 258-261.
30. HUSBY, S., J. MESTECKY, Z. MOLDOVEANU, S. HOLLAND & C. O. ELSON. 1994. Oral tolerance in humans: T cell but not B cell tolerance after antigen feeding. J. Immunol. 152: 4663-4670.
31. SALK, R. J. S. 1983. A study of myelin basic protein as a therapeutic probe in patients with multiple sclerosis. In Multiple Sclerosis. J. F. Hallpike, C. W. M. Adams & W. W. Tourtellotte, Eds.: 621-630. Chapman & Hall. London.
32. MOSMANN, T. R. & S. SAD. 1996. The expanding universe of T-cell subsets: Th1, Th2, and more. Immunol. Today 17: 138-146.